![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)
探索CPPC作为一个CSF1R向的PET成像标记器,用于早期帕金森病的严重程度
Kelly A Mills1, Yong Du2, Jennifer M Coughlin1,3
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
medRxiv : the preprint server for health sciences
|July 3, 2023
概括
殖民地刺激因子1受体 (CSF1R) 在帕金森病 (PD) 大脑中升高,表明其作为生物标志物的潜力. [11C]CPPC-PET对CSF1R的成像可以追踪PD的进展和严重程度.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 放射化学 放射化学是指辐射化学.
背景情况:
- 由天生的免疫驱动的神经炎症与帕金森病 (PD) 病原发生有关.
- 目前用于PD的神经成像方法缺乏针对免疫细胞的特异性.
- 殖民地刺激因子1受体 (CSF1R) 对微质功能至关重要,是神经炎症的关键参与者.
研究的目的:
- 研究CSF1R作为帕金森病中神经炎症的潜在生物标志物.
- 评估[11C]CPPC-PET成像用于评估PD相关的运动和认知障碍的实用性.
主要方法:
- 在人脑组织中对CSF1R和Iba1 (微质标记物) 的免疫组合化学分析.
- 使用 [3H]JHU11761 测量CSF1R结合的自发放射.
- 用[11C]CPPC进行正子发射断层扫描 (PET) 成像,以在体内定量CSF1R.
主要成果:
- 与对照人群相比,在PD患者的多个大脑区域中,CSF1R的表达显著增加,特别是在中脑.
- [11C]CPPC-PET结合在条纹体与PD患者的运动残疾相关.
- 在各种大脑区域增加[11C]CPPC结合与更严重的运动残疾和较差的语言流性有关.
结论:
- 在帕金森病中,CSF1R被上调,突出显示了它在疾病过程中的作用.
- [11C]CPPC-PET对CSF1R的成像显示出对非侵入性评估神经炎症,运动缺陷和PD认知障碍的有希望.
- CSF1R作为一种潜在的生物标志物,用于跟踪疾病的进展和严重程度,有助于早期诊断和向治疗.
相关概念视频
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...